CHD/Prevention News

Higher levels of life satisfaction and well-being may portend lower rates of CVD due to the association between inflammatory markers and CV risk factors observed among individuals reporting lower well-being, researchers reported.

Adults who drink caffeinated beverages such as coffee or tea may have a lower risk for developing multiple cardiometabolic diseases compared with adults with low or no intake, according to study findings.

Many recently recalled cardiovascular devices did not undergo premarket testing prior to FDA approval, and postmarket studies of the devices were slow and infrequent, researchers reported.

Catching up on sleep over the weekend was associated with lower likelihood of having heart disease compared with individuals who slept less than they would during the week, a speaker reported.

In patients with obesity and heart disease, semaglutide 2.4 mg reduced risk for major adverse cardiovascular events regardless of baseline kidney function, according to new data from the SELECT trial.

Hypertension remains a prevalent concern among youth and young adults in the U.S., especially among those living with adverse social conditions, speakers reported.

High- vs. standard-dose influenza vaccine was linked to a lower incidence of mortality and hospitalizations for pneumonia or influenza regardless of chronic CVD, according to a study presented at the European Society of Cardiology Congress.

CHICAGO — Hormone therapy use among menopausal women has fallen to just 1.8% as of 2023, data show, despite evidence and clinical guidance suggesting HT is safe and effective for most women for bothersome menopausal symptoms.

Tirzepatide is associated with similar odds for gastrointestinal adverse events and a lower likelihood for diabetic retinopathy and pancreatitis compared with GLP-1 receptor agonists, according to a presenter.